Constipation Treatment Market Competition Analysis 2025: How Players Are Shaping Growth
Constipation Treatment Global Market Report 2026
The Business Research Company's Constipation Treatment Global Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, January 8, 2026 /EINPresswire.com/ -- "The Constipation Treatment market is dominated by a mix of global pharmaceutical leaders and specialized gastrointestinal (GI) therapy manufacturers. Companies are focusing on expanding therapeutic portfolios, accelerating R&D for targeted constipation drugs, and strengthening distribution networks across hospital, retail, and online pharmacies. With rising disease prevalence, increasing OTC adoption, and growing demand for personalized GI care, understanding the competitive landscape is essential for stakeholders aiming to capture emerging opportunities and form strategic collaborations.
Which Market Player Is Leading the Constipation Treatment Market?
According to our research, AbbVie Inc. led global sales in 2024 with a 8% market share. The Gastroenterology division of the company completely involved in the constipation treatment market provides the treatments for conditions like irritable bowel syndrome (IBS) and chronic idiopathic constipation.
The Women's Health division of the company completely involved in the constipation treatment market provides, products addressing conditions such as uterine fibroids and endometriosis.
The Anti-Infectives division of the company completely involved in the constipation treatment market provides, antibiotics and antifungal medications.
The Cardiovascular division of the company completely involved in the constipation treatment market provides, treatments for hypertension and other cardiovascular diseases.
How Concentrated Is the Constipation Treatment Market?
The market is fragmented, with the top 10 players accounting for 21% of total market revenue in 2024. This level of fragmentation reflects the wide availability of OTC laxatives, dietary supplements, natural formulations, and prescription therapies, giving consumers multiple avenues for symptom management. Leading companies such as AbbVie Inc, Bausch Health Companies Inc, Ironwood Pharmaceuticals Inc, Ardelyx Inc, and Procter & Gamble—maintain an edge through strong product portfolios, established brand trust, prescription market leadership, and extensive retail and pharmacy distribution networks. Despite this, the market offers significant scope for innovation, particularly in chronic idiopathic constipation (CIC), IBS-C, CKD-associated constipation, behavioural-digital therapies, and microbiome-based interventions. As unmet patient needs persist and demand shifts toward more personalized and long-term management solutions, both major pharmaceutical manufacturers and emerging biotech firms have substantial opportunities to grow. The competitive landscape in 2024 was led by AbbVie Inc, Bausch Health Companies Inc, Ironwood Pharmaceuticals Inc, Ardelyx Inc, Procter & Gamble, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Ltd, Abbott Laboratories, Cipla Ltd, and Fresenius SE.
• Leading companies include:
o AbbVie Inc. (3%)
o Bausch Health Companies Inc. (TRULANCE®) (3%)
o Ironwood Pharmaceuticals Inc. (LINZESS) (3%)
o Ardley Inc. (3%)
o Procter & Gamble (3%)
o Boehringer Ingelheim International GmbH (Dulcolax) (2%)
o Takeda Pharmaceutical Company Ltd. (2%)
o Abbott Laboratories (2%)
o Cipla Ltd. (Easylax) (1%)
o Fresenius SE (0.2%)
Request a free sample of the Constipation Treatment Market report:
https://www.thebusinessresearchcompany.com/sample_request?id=12134&type=smp
Which Companies Are Leading Across Different Regions?
• North America: Takeda Pharmaceutical Company Limited, Ironwood Pharmaceuticals, Inc, Salix Pharmaceuticals, Inc, Abbott Laboratories, AbbVie Inc, AstraZeneca PLC, Sanofi S.A, Knight Therapeutics Inc and Bayer AG are leading companies in this region.
• Asia Pacific: Imuran Limited, Cadila Pharmaceuticals Ltd, Dr. Reddy's Laboratories Ltd, Lupin Limited, Shionogi & Co, Ltd, EA Pharma Co, Ltd, Mochida Pharmaceutical Co, Ltd, Takeda Pharmaceutical Company Limited, Daewoong Co, Ltd, Hanmi Pharm Co, Ltd and Chong Kun Dang Pharmaceutical Corp are leading companies in this region.
• Western Europe: Biocodex S.A, Grünenthal GmbH, Kelso Pharma Limited, Navamedic ASA, Reckitt Benckiser Group plc, GlaxoSmithKline plc, Bayer AG, Sanofi S.A, Ipsen S.A, Pierre Fabre S.A, Novartis AG, Johnson & Johnson, Almirall, S.A, Angelini Pharma S.p.A, Takeda Pharmaceutical Company Limited and Cosmo Pharmaceuticals N.V are leading companies in this region.
• Eastern Europe: Gedeon Richter Plc, Krka, d. d, Norgine B.V, Grünenthal GmbH, Biocodex S.A, Aflofarm Farmacja Polska Sp. z o.o, Sanofi S.A, Bayer AG, Abbott Laboratories, Teva Pharmaceutical Industries Ltd and STADA Arzneimittel AG are leading companies in this region.
• South America: Takeda Pharmaceutical Company Limited, Abbott Laboratories, AstraZeneca PLC, Sanofi S.A, Bayer AG, Daewoong Pharmaceuticals Co, Ltd, Bausch Health Companies Inc and Janssen Pharmaceuticals, Inc are leading companies in this region.
What Are the Major Competitive Trends in the Market?
• Expansion of targeted therapies to address opioid-induced constipation (OIC) is enhancing patient quality of life (QOL) and filling gaps where standard treatments such as laxatives may be inadequate.
• Example: Shionogi & Co, Ltd New Drug Application (NDA) (May 2025) assigns advance its gastrointestinal portfolio and capitalise on the growing demand for targeted OIC therapies.
• These innovations in pharmacologic option in a market where treatment was largely symptomatic and supportive.
Which Strategies Are Companies Adopting to Stay Ahead?
• Launching new products and solutions to strengthen market position
• Enhancing R&D investment to develop innovative therapies and novel drug formulations
• Focusing on patient-centric digital health solutions and adherence monitoring
• Leveraging global distribution networks and retail pharmacy partnerships for wider market reach
Access the detailed Constipation Treatment Market report here:
https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. We have published over 17,500 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package and much more.
Disclaimer: Please note that the findings, conclusions and recommendations that TBRC Business Research Pvt Ltd delivers are based on information gathered in good faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such TBRC Business Research Pvt Ltd can accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect. Analysis and findings included in TBRC reports and presentations are our estimates, opinions and are not intended as statements of fact or investment guidance.
The Business Research Company
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email: info@tbrc.info"
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
